Neonatal Persistent Pulmonary Hypertension Treated with Milrinone: Four Case Reports
Authors:
- Dirk BasslerDBDirk Bassler
- Karen ChoongKCKaren Choong
- Patrick McNamaraPMPatrick McNamara
- Haresh KirpalaniHKHaresh Kirpalani
- 1 January 2006
- journal article
- case report
- Published by S. Karger AG in Neonatology
- Vol. 89 (1) , 1-5
Abstract
Current standard therapy forpersistent pulmonary hypertension of the newborn (PPHN) consists of optimal lung inflation, hemodynamic support and selective vasodilation with inhaled nitric oxide (iNO). However, not all infants will respond. Milrinone, a phosphodiesterase (PDE) III inhibitor, is routinely used in pediatric cardiac intensive care units to improve inotropy and reduce afterload. Although its use in post-operative cardiac failure has been proven in a randomized trial, it has not been reported to be beneficial in PPHN. We report four cases with severe PPHN treated with a combination of iNO and Milrinone. All four cases were unresponsive to therapy including iNO, with a mean oxygenation index (OI) of 40 (standard deviation (SD) 12)) before Milrinone. Substantial improvement in OI (mean of 28; SD 16) was followed by extubation and survival. However, of 4 patients, 2 developed serious intraventricular hemorrhages (IVHs), and 1 had a small IVH. To clarify the risk benefit ratio, of death versus survival with impairment, a randomized controlled trial is needed.Keywords
This publication has 8 references indexed in Scilit:
- 133 Pilot Study of Milrinone for Prevention of Low Systemic Blood Flow in Very Preterm InfantsPediatric Research, 2004
- Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs*Pediatric Critical Care Medicine, 2004
- Pulmonary Responses to Selective Phosphodiesterase-5 and Phosphodiesterase-3 InhibitorsChest, 2004
- Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A reviewPediatric Pulmonology, 2003
- Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart DiseaseCirculation, 2003
- Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertensionCritical Care Medicine, 2000
- Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory FailureNew England Journal of Medicine, 1997
- Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertensionCritical Care Medicine, 1991